(It) will save lives, improve the health of millions and millions of Americans, said Trump, in an Oval Office announcement in which he referred to GLP-1 as a fat drug. Thursdays announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters
Insurance formulary coverage, manufacturer savings programs, and generic biosimilar pathways entering the market in 2026 further reduce cost and access barriers for most patients
Antioxidants can help combat excessive free radicals and pro-inflammatory states
Inspect solution for clarity before administration
FDA Adds New Side Effect Warning to Ozempic Label Popular semaglutide injectable Ozempic will now have a warning about intestinal blockage after the Food and Drug Administration accepted manufacturer Novo Nordisks proposed changes to the drugs packaging
The health care system is experiencing a dramatic shift in how medication access is covered, largely driven by employers desire to offer programs that best meet workforce needs, said Lisa Gill, a senior analyst covering Managed Care at J.P
